The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A confirmatory trial of modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumor diameter preoperatively estimated at 2 cm or less: Japan Clinical Oncology Group study, JCOG1101.
 
Takahide Arimoto
No Relationships to Disclose
 
Takahiro Kasamatsu
No Relationships to Disclose
 
Takafumi Toita
No Relationships to Disclose
 
Hiroaki Kobayashi
No Relationships to Disclose
 
Ryunosuke Machida
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - m3.com
 
Takashi Onda
Research Funding - Daiichi Sankyo (Inst)
 
Toru Nakanishi
No Relationships to Disclose
 
Harushige Yokota
No Relationships to Disclose
 
Shoji Kamiura
No Relationships to Disclose
 
Kazuhiro Takehara
Honoraria - Abbvie; AstraZeneca; Chugai Pharma; Eisai; Fuji Pharma; Mochida Pharmaceutical Co. Ltd.; MSD; Nippon Kayaku; Taiho Pharmaceutical; Takeda; Zeria Pharmaceutical
Research Funding - Chugai Pharma
 
Hirokuni Takano
No Relationships to Disclose
 
Toshiaki Saito
No Relationships to Disclose
 
Ikuo Konishi
No Relationships to Disclose
 
Satoshi Yamaguchi
No Relationships to Disclose
 
Toshiaki Nakamura
No Relationships to Disclose
 
Kimio Ushijima
Honoraria - AstraZeneca; Asuka Seiyaku; Chugai Pharma; Kaken Pharmaceutical; Kyowa Kirin International; Mochida Pharmaceutical Co. Ltd.; MSD; Sanofi; Takeda; Zeria Pharmaceutical
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); Kaken Pharmaceutical (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); MSD (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Daisuke Aoki
Honoraria - AstraZeneca; Chugai Pharma; Eisai Europe; Eisai/MSD; Genmab; MSD; Myriad Genetics; Sysmex; Takeda
Consulting or Advisory Role - AstraZeneca; MSD; Takeda
Research Funding - Sysmex (Inst)
 
Nobuo Yaegashi
No Relationships to Disclose
 
Toyomi Satoh
No Relationships to Disclose